Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-59781

ABSTRACT: Transcription profiling by high throughput sequencing of control- and PAX2-siRNA-transfected human epididymis epithelial cells

OTHER RELATED OMICS DATASETS IN: PRJNA256192PRJNA256193PRJNA256190PRJNA258154

PROVIDER: E-GEOD-59781 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-59781-analysis-methods.tsv	Tabular
	E-GEOD-59781-analytics.tsv	Tabular
	E-GEOD-59781-analytics.tsv.undecorated	Tabular
	E-GEOD-59781-analytics.tsv.undecorated.unrounded	Tabular
	E-GEOD-59781-analytics.tsv.unrounded	Tabular

Items per page:

1 - 5 of 33

Similar Datasets

RNA sequencing data of OTUB1-knockdown in PDGF-BB-treated HASMCs

Project description:We report the high-throughput RNA sequencing on human aortic smooth muscle cells (HASMCs) transfected with siRNA targeting OTUB1 (si-OTUB1) or control siRNA (si-NC). Cells were treated with PDGF-BB for 48 hours.

2025-05-07 | GSE232121 | GEO

siIGF2BP3 regulated genes in lung cancer cell

Project description:To investigate the global genes regulated by siIGF2BP3 high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between PC3 cells transfected with control siRNA or siIGF2BP3 siRNA.

2023-05-13 | GSE150594 | GEO

FTO regulated genes in Hepatocellular Carcinoma

Project description:To investigate the global genes regulated by FTO high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between HepG2 cells transfected with control siRNA or FTO siRNA.

2023-05-10 | GSE150260 | GEO

AHR regulated genes in Colorectal Cancer

Project description:To investigate the global genes regulated by AHR, high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between DLD-1 cells transfected with control siRNA or AHR siRNA.

2023-05-01 | GSE149867 | GEO

High-throughput RNA sequencing analysis of human nasopharyngeal carcinoma cell line HK1 transfected with E2F1 siRNA or E2F3 siRNA

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are using RNA sequencing analysis to evaluate the effects of si-E2F1 (or E2F3) on the mRNA of human nasopharyngeal carcinoma cell line HK1. Methods: Human nasopharyngeal carcinoma cell line HK1 was transfected with a control non-targeting siRNA to cells or transfected with siRNA targeting E2F1 (or E2F3) for 48 hours in DMEM medium (with 10% serum). Total RNA were extracted and detected by Illumina high-throughput RNA sequencing data analysis. 3 independent biological replicates were plated, transfected in parallel for each control and siRNA. Results: Log-fold changes of up- or down-regulated mRNAs between the control and experiment group were selected with a significance threshold of p<0.05. Conclusions: Our study describes the mRNA changes of human nasopharyngeal carcinoma cell line HK1 transfected with E2F1 (or E2F3) siRNA.

2020-10-11 | GSE138752 | GEO

High-throughput RNA sequencing analysis of human colon cancer cell line HCT116 transfected with LINC00152 siRNA.

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are using RNA sequencing analysis to evaluate the effects of si-LINC00152 on the mRNA of human colon cancer cell line HCT116. Methods: Human colon cancer cell line HCT116 was transfected with a control non-targeting siRNA to cells or transfected with siRNA targeting LINC00152 for 36 hours in DMEM medium (with 10% serum). Total RNA were extracted and detected by Illumina high-throughput RNA sequencing data analysis. 2 independent biological replicates were plated, transfected in parallel for each control and siRNA. Results: Log-fold changes of up- or down-regulated mRNAs between the control and experiment group were selected with a significance threshold of p<0.05. There are 90 mRNAs were up-regulated and 159 were down-regulated in “si-LINC00152” group comparing to “control” group. Conclusions: Our study describes the mRNA changes of human colon cancer cell line HCT116 transfected with LINC00152 siRNA.

2020-02-18 | GSE132519 | GEO

lncSLCC1(RP11-400N13.2)-regulated genes in Colorectal Cancer

Project description:To investigate the global genes regulated by lncRNA-SLCC1(RP11-400N13.2), high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between DLD-1 cells transfected with control siRNA or lncSLCC1 siRNA.

2023-05-01 | GSE149783 | GEO

METTL3 regulated genes in HCC cell

Project description:To investigate the global genes regulated by METTL3 high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between Huh7cells transfected with control siRNA or METTL3 siRNA.

2023-05-13 | GSE150489 | GEO

FTO regulated genes in bladder cancer cell

Project description:To investigate the global genes regulated by FTO high-throughput mRNA sequencing (RNA-Seq) was performed to compare the expression profile between 253Jcells transfected with control siRNA or FTO siRNA.

2021-07-29 | GSE150239 | GEO

miRNA regulatory landscape of EMT [mRNA-seq]

Project description:To investigate the transcriptional remodelling during EMT, we transfected normal murine mammary gland epithelial cells during a 4d TGFbeta treatment individually with siRNA against 46 transcription (co)factors or with 13 mature miRNA, all factors that blocked EMT in a phenotypic microscopy-based EMT screen upon RNAi . As a control, cells were transfected with siRNA/miRNA control followed by 4d TGFbeta treatment (mesenchymal control) or were left untreated (epithelial control). miRNA-sequencing together with mRNA-sequencing of these EMT perturbations in combination with transcription factor binding and miRNA target prediction enabled us to build an interaction map between these EMT factors.

2021-04-06 | GSE115375 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data